The Procter & Gamble Company (NYSE:PG) Stake Increased by Accordant Advisory Group Inc

Accordant Advisory Group Inc grew its stake in shares of The Procter & Gamble Company (NYSE:PG) by 54.2% in the 3rd quarter, Holdings Channel.com reports. The fund owned 461 shares of the company’s stock after purchasing an additional 162 shares during the quarter. Accordant Advisory Group Inc’s holdings in Procter & Gamble were worth $80,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of PG. Itau Unibanco Holding S.A. bought a new stake in Procter & Gamble during the second quarter valued at $28,000. Fairway Wealth LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $29,000. Ruedi Wealth Management Inc. raised its stake in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares during the period. POM Investment Strategies LLC bought a new position in Procter & Gamble in the second quarter worth about $34,000. Finally, Quest Partners LLC acquired a new position in Procter & Gamble in the second quarter valued at approximately $36,000. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

PG opened at $169.73 on Wednesday. The business has a fifty day simple moving average of $171.87 and a 200-day simple moving average of $167.43. The firm has a market cap of $400.59 billion, a PE ratio of 29.26, a P/E/G ratio of 3.72 and a beta of 0.41. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $177.94.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the previous year, the company earned $1.83 EPS. The business’s revenue for the quarter was down .6% compared to the same quarter last year. As a group, equities analysts predict that The Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.37%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s payout ratio is 69.48%.

Insider Buying and Selling at Procter & Gamble

In other news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO R. Alexandra Keith sold 3,373 shares of the business’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $170.00, for a total transaction of $573,410.00. Following the transaction, the chief executive officer now directly owns 21,513 shares in the company, valued at $3,657,210. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 383,194 shares of company stock valued at $65,140,718 in the last three months. 0.18% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

PG has been the topic of several recent research reports. Stifel Nicolaus raised their price target on Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a report on Monday, July 22nd. Piper Sandler started coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target for the company. Citigroup lifted their price objective on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a research report on Wednesday, July 10th. TD Cowen assumed coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 target price for the company. Finally, Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $177.00.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.